Interleukin 1 receptor-associated kinase m impairs host defense during pneumococcal pneumonia

Gerritje J W van der Windt1, Dana C Blok, Jacobien J Hoogerwerf

  • 1Center for Infection and Immunity Amsterdam, University of Amsterdam, The Netherlands.

Abstract

Insights

Interleukin 1 receptor-associated kinase-M (IRAK-M) impairs host defense against Streptococcus pneumoniae pneumonia. IRAK-M deficiency enhances early immune responses, reducing bacterial load and lethality in mice.

Area of Science:

  • Immunology
  • Microbiology
  • Infectious Diseases

Background:

  • Streptococcus pneumoniae is a leading cause of community-acquired pneumonia.
  • Innate immune cells recognize pneumococci via pattern recognition receptors like Toll-like receptors (TLRs).
  • Interleukin 1 (IL-1) receptor-associated kinase-M (IRAK-M) acts as a proximal inhibitor of TLR signaling.

Purpose of the Study:

  • To investigate the role of IRAK-M in host defense during pneumococcal pneumonia.
  • To understand how IRAK-M influences the immune response to Streptococcus pneumoniae infection.

Main Methods:

  • Intranasal infection of IRAK-M-deficient and wild-type mice with Streptococcus pneumoniae.
  • Comparison of bacterial burdens, lethality, and immune cell infiltration between mouse strains.
  • Measurement of pulmonary cytokine levels (IL-1β, CXCL1).

Main Results:

  • IRAK-M-deficient mice exhibited reduced lethality following airway infection with S. pneumoniae.
  • A significant decrease (10-100 fold) in bacterial recovery from lungs and distant sites was observed in IRAK-M-deficient mice from 24 hours post-infection.
  • Enhanced neutrophil influx and elevated IL-1β and CXCL1 levels were noted in IRAK-M-deficient mice, correlating with diminished bacterial dissemination.

Conclusions:

  • IRAK-M impairs host defense against pneumococcal pneumonia at the infection site.
  • Inhibition of the early immune response by IRAK-M contributes to increased bacterial burden and severity.
  • Targeting IRAK-M may represent a therapeutic strategy to bolster host defense against pneumococcal infections.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...